Efficacy of testosterone replacement treatment for patients with symptoms of late-onset hypogonadism based on real-world patient satisfaction.

Testosterone replacement treatment (TRT) resulted in patient satisfaction in 70.0% of men with low testosterone.

• Study comprised 110 men with low testosterone concentration of <3.0 ng/mL who underwent TRT.
• 77 of 110 patients (70.0%) were satisfied with the treatment.
• TRT was administered as intramuscular injection of 250 mg of testosterone esters every 2-4 weeks.
• Efficacy was judged by patient satisfaction after confirming treatment response.

TRT was effective across mental, physical, and sexual dysfunction domains at different rates.

• TRT was effective in 65.7% of patients with mental dysfunction.
• TRT was effective in 71.4% of patients with physical dysfunction.
• TRT was effective in 73.1% of patients with sexual dysfunction.
• Efficacy rates were assessed based on patient satisfaction within each dysfunction category.

Questionnaire scores including the Aging Males Symptoms (AMS) rating scale were significantly improved in both the satisfaction and non-satisfaction groups.

• Significant improvements in questionnaire scores were observed regardless of whether patients reported satisfaction with TRT.
• Both the satisfaction group and non-satisfaction group showed significant improvements in AMS scores.
• This finding indicates that questionnaire score improvement alone does not distinguish satisfied from unsatisfied patients.

No significant differences in the amount of change in questionnaire scores were found between the satisfaction and non-satisfaction groups.

• No significant differences were found for all questionnaire scores improved by TRT between the satisfaction and non-satisfaction groups.
• Patient satisfaction was not associated with improvement of the Aging Males Symptoms score.
• This suggests that the magnitude of questionnaire score improvement does not predict patient satisfaction with TRT.

Patient satisfaction did not correlate with improvement of questionnaire scores, indicating the two measures capture different aspects of treatment efficacy.

• The study compared evaluation by patient satisfaction versus evaluation by questionnaire scores.
• The AMS rating scale and other questionnaires improved significantly, yet this did not align with patient satisfaction outcomes.
• The authors concluded that not only questionnaire results but also patient satisfaction is important when evaluating efficacy in patients undergoing TRT.
• The discordance between objective questionnaire improvements and subjective satisfaction highlights the limitation of using questionnaires alone as efficacy endpoints in real-world clinical settings.